Selective Activation of Ha-rasval12Oncogene Increases Susceptibility of NIH/3T3 Cells to TNF-α
- 1 May 1999
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 248 (2), 589-598
- https://doi.org/10.1006/excr.1999.4436
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Ha-rasVal12Oncogene Increases Susceptibility of NIH/3T3 Cells to LovastatinBiochemical and Biophysical Research Communications, 1998
- A ribozyme specifically suppresses transformation and tumorigenicity of Ha-ras-oncogene-transformed NIH/3T3 cell linesZeitschrift für Krebsforschung und Klinische Onkologie, 1997
- Ras-mediated cell proliferation and cell death: some clues from the interleukin-2 receptor systemApoptosis, 1996
- Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell DeathCell, 1996
- Fibroblast Growth Factor-2 Suppression of Tumor Necrosis Factor α-Mediated Apoptosis Requires Ras and the Activation of Mitogen-activated Protein KinaseJournal of Biological Chemistry, 1996
- Oncogenes and cell deathCurrent Opinion in Genetics & Development, 1994
- The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domainCell, 1993
- Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase.Genes & Development, 1992
- Tumor necrosis factor Characterization at the molecular, cellular and in vivo levelFEBS Letters, 1991
- A FOS protein is present in a complex that binds a negative regulator of MYC.Genes & Development, 1989